Sergio Martínez: “Combining existing drugs could impact clinical practice much faster than developing new therapies”
Nerea Clemente: “Working in DocTIS has shown me how complex it is to move from research to clinical application”
DocTIS granted six-month extension to complete its clinical trial in immune-mediated inflammatory diseases
Pere Santamaria: “By combining drugs intelligently, patients who do not respond to monotherapies can be helped”
